A new study finds that taking arginine orally may lower amyloid buildup and neuroinflammation, suggesting a safe, low-cost ...
Diabetes and weight loss drug semaglutide has been trialled in people with Alzheimer's. We explain what it means for dementia ...
On its own, LATE dementia is less severe than Alzheimer’s, but in combination, it makes Alzheimer’s symptoms worse, ...
The Brighterside of News on MSN
The body’s hidden weapon against Alzheimer’s disease: muscles
Alzheimer’s disease steals memory, independence and, too often, life itself. Drugs can ease symptoms, but none halt the march ...
A new study suggests that arginine, a common amino acid, may help reduce the brain plaques associated with Alzheimer’s ...
Dementia is the deterioration of brain functioning beyond that of normal ageing. There are multiple types, the most common being Alzheimer’s disease. Factors such as smoking, being overweight, heavy ...
Semaglutide does influence processes linked to Alzheimer’s, but these trials suggest it does not slow symptoms once they ...
Understanding the human brain is essential in science. Now, it has been discovered that the shape of the brain, and not just ...
Since the landmark approvals of lecanemab and donanemab, anti-amyloid immunotherapy has marked a paradigm shift in ...
Background Hypertension is a significant risk factor for cardiovascular disease, dementia and chronic kidney disease (CKD).
TORONTO, Nov. 28, 2025 /CNW/ - The Centre for Aging + Brain Health Innovation (CABHI), powered by Baycrest, has allocated $2.8 million CAD in funding to ...
The DaRe2THINK platform – developed by the University of Birmingham and the MHRA's Clinical Practice Research Datalink (CPRD) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback